Laurent Schueller

Participatiemaatschappij Vlaanderen NV (PMV) is a private equity/venture capital firm, a subsidiary of Region of Flanders founded in 1995. Participatiemaatschappij Vlaanderen NV is headquartered in Brussels, Belgium.

Johnson & Johnson Pharmaceutical Research & Development LLC provides research and development support services. It offers drug discovery and drug development in a variety of therapeutic areas, including CNS, Internal Medicine and Oncology, to address unmet medical needs worldwide. The company is headquartered in Raritan, NJ.

MyCartis NV develops technologies for healthcare personalization needs. It offers Evalution, a multiplex analysis platform to develop protein and nucleic-acid based clinical biomarkers. The company provides disruptive solutions in the fields of clinical and translational research for various applications in the detection of proteins and nucleic acids, such as sandwich immunoassays, antibody assays, genotyping assays, and mutation analysis assays to customers and partners. It offers products for various disease areas, including cell signalling, cardiovascular, oncology, and preeclampsia. The company was founded by Koen Kas in August 2004 and is headquartered in Ghent, Belgium.

Janssen Pharmaceutica NV engages in the development of medical solutions. It offers research and development services in the field of mental illness, neurological disorders, anesthesia, analgesia, gastrointestinal disorders, fungal infection, allergies and cancer. The firms products include Zytiga, Caelyx, Dacogen, Edurant, Fentanyl-Janssen, Intelence, Leustatin, , Pariet, and Reminyl. The company was founded in 1953 by Paul Janssen and is headquartered in Beerse, Belgium.

Allegro Investment Fund is a venture capital investment firm founded in 2004. Allegro Investment Fund is headquartered in Leuven, Belgium.

Hunza Management SARL is a private equity firm headquartered in Luxembourg. The current firm was established in 1998 to manage Hunza Ventures, the venture capital investment vehicle of the family of the retired Belgian entrepreneur Guy Ullens. Baron Guy Ullens de Schooten and the Wittouck family built up and controlled the diversified European food manufacturing group Artal, based in Luxembourg and historically focused on the Belgian sugar industry.

Axilius NV manufactures transformers and lathes. The company is headquartered in Leuven, Belgium.

Today, the ongoing migration from traditional CCTV analogue video systems to IP (Internet Protocol) based Video monitoring systems is happening at a very fast pace. If you combine these new technologies with the near ubiquitous availability of mobile data over Mobile (GSM) networks, you can imagine what you can do: Get true 'live' video from everywhere from anywhere on every device. iNEWiT has understood that not only the ability to use video over IP networks is the true revolution, but to enable a 'mobile component' is one of the real benefits that is brought to consumers, companies or even public services. Imagine the applications that you enabling by getting 'live video' straight onto people's mobile devices. The company therefore focuses on serving their customers with 3 main types of solutions: - The VIU Wireless Video Guard family for home monitoring and reassurance, aimed at consumers and small businesses. - The VIU PRO fully integrated multi-component video monitoring solutions aimed at business, industrial and government applications. - The MOVE and Video, a solution aimed at transport services, public transport and car- or truck fleets. This compact solution allows monitoring of vehicles whilst allowing users to view 'live' video from (within) the vehicle. The 'Video' component complements the MOVE solution by enabling 'narrowcasting' on in-vehicle screens.

Leuven Air Bearings NV develops and produces air bearing solutions. It provides services to industrial automation, process control, compressor and power generation industries. The company was founded by Farid Al-Bender in 2006 and is headquartered in Leuven, Belgium.

reMYND NV engages in the development of disease-modifying treatments against alzheimer's, parkinson's, diabetes and other protein misfolding disorders. Its drug and development unit focuses on innovative, disease-modifying drugs for treating degenerative disorders. The company was founded by Fred Van Leuven, Stefaan Wera and Joris Winderickx in 2002 and is headquartered in Leuven, Belgium.

Magnets for Emulsions NV provides magnetic technology for production of emulsions and the dissolution of powders. It offers tailor made magnetic devices and installations for emulsion and powder dissolving applications as well as to facilitate incorporation of M4E technology in existing process installations. The firms’ technology is used in areas such as cosmetics and pharma, mayonnaise and sauces and biodiesel. The company was founded by Filip Troch, Dirk Packet, Firmin Velghe, Jan Nuyens and Johan A. Martens in October 2004 and is headquartered in Heverlee, Belgium.

Vesalius Biocapital I SA Sicar focuses on healthcare companies that are in the early stage or that are corporate spin-offs. The fund invests mainly in Europe with a more precise focus on the Benelux countries. Vesalius invests up to EUR 10 million and may invest a few hundred thousand euros in a seed project.

FlandersBio vzw is a life sciences cluster organization based in Flanders, Belgium. FlandersBio creates value by organizing networking and training activities, supporting internationalization, providing services, and building expertise. The Belgian company was founded by Jean Marie Stassen.

Amakem NV operates as a biopharmaceutical company. It uses kinase inhibitors for treatments of bowel, eye, and lung diseases. The company was founded by Jack Elands, Dirk Leysen, Olivier Raynald Defert, and Nadya Kaval on July 22, 2009 and is headquartered in Diepenbeek, Belgium.

Exact Imaging, Inc. provides high resolution micro-ultrasound systems enabling real-time imaging and guided biopsies in the urological market for prostate cancer. Its ExactVu micro-ultrasound platform operates at 29 MHz and enables a whole new level of resolution with the benefits of ease of use, affordability, and being an extension of the current urological workflow. The company was founded by Sam Ifergan and Randy AuCoin in 2013 and is headquartered in Markham, Canada.

Vesalius Biocapital II SA Sicar focuses on healthcare companies that are in the early stage or that are corporate spin-offs. The fund invests mainly in Europe with a more precise focus on the Benelux countries. Vesalius invests up to EUR 10 million and may invest a few hundred thousand euros in a seed project.

iTeos Therapeutics SA engages in the discovery of immunomodulators for cancer therapy. It operates as a biotechnology company which focuses on targeting metabolism of the tumor microenvironment through development of small-molecule immunomodulators for cancer treatment. The firm develops small molecules designed to target the tumor microenvironment by inhibiting cancer-induced immune suppression. Targeting such resistance mechanisms will enhance the clinical efficacy of both standards of care treatments as well as the newer immunomodulatory therapies based on the blockade of immune checkpoints. The company was founded in 2011 by Michel Detheux and Benoit Van den Eynde and is headquartered in Gosselies, Belgium.

eSATURNUS NV provides healthcare services for hospitals, doctors, nursing staff, and patients. The company was founded by Thomas Koninckx and Bob Koninckx on April 6, 2007 and is headquartered in Leuven, Belgium.

FEops NV develops novel simulation technology. It provides cardiovascular device and procedure simulation advice to medical device companies, as well as to medical specialists and physicians. The firm develops disruptive technology: a cloud-based simulation platform designed to assist clinicians in assessing the effect of device-and-host interaction, with the ultimate goal of predicting and preventing complications of transcatheter-based structural heart interventions. The company was founded by Benedict Verhegghe, Matthieu De Beule and Peter Mortier in 2009 and is headquartered in Ghent, Belgium.

Aqua4c NV operates a fish farm. The company was founded on October 23, 2013 and is headquartered in Ghent, Belgium.

Fund+ is an independent Venture Capital firm founded in 2015. The firm is headquartered in Leuven, Belgium.

Confo Therapeutics NV develops pharmaceutical products. It is a drug discovery company building internal drug discovery programs on GPCRs addressing unmet medical need. The company was founded by Jan Steyaert and Toon Laeremans in June 2015 and is headquartered in Brussels, Belgium.

eTheRNA immunotherapies NV develops novel immunotherapies to overcome cancers and infectious diseases. The company was founded by Carlo Heirman, Kris Thielemans and Sonja van Meirvenne in January 21, 2013 and is headquartered in Niel, Belgium.

EPICS Therapeutics SA engages in the development of therapeutic solutions for cancer. The company was founded by Jean Combalbert, Alain Parthoens and Francois Fuks on February 20, 2018 and is headquartered in Charleroi, Belgium.

Ona Therapeutics SL is a biotech company based in Barcelona, Spain that specializes in discovering and developing therapeutic biologics targeting tumor metastatic-initiating cells and lipid metabolism. The Spanish company's focus is on developing novel therapies against advanced cancer. The company was founded in 2019 by Salvador Aznar Benitah and Valerie Liesbeth Brigitte Vanhooren, with Valerie Liesbeth Brigitte Vanhooren serving as CEO since incorporation.

Oncode BV is a venture capital firm, a subsidiary of Oncode Institute, founded in 2018. Oncode BV is headquartered in Utrecht.